CA
Cantargia Stock: price and insider trades · Sweden
ISIN SE0009522568SE·
No insider purchase over the last 90 days. The latest, by Lars Harald Thorsson, was filed 07 Feb 2017.
Cantargia: what insiders have been doing
We have very little insider data for Cantargia so far: the most recent filing dates from 7 February 2017. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€6,870
1 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 7 February 2017
Declarations1 total
- 9,998 shares@ SEK 6.50100.0% of flowISIN SE0009522568FI:csv-2d43b049c7970d737ce9Canonical exit: 7 May 2017 (T+90)
1 of 1 declaration
About Cantargia
Cantargia is a biopharmaceutical company focused on developing treatments for cancer and inflammatory diseases. It is listed on the Stockholm Stock Exchange, XSTO.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations